We are live on ! Find out more
DS

David Shaw D.E. Shaw & Co

AUM $210B
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+7.83%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.65%
5 Year Est. Return
+213.13%
10 Year Est. Return
+910.08%
AUM
$104B
AUM Growth
-$8.26B
Cap. Flow
-$18.3B
Cap. Flow %
-17.65%
Top 10 Hldgs %
9.93%
Holding
4,712
New
825
Increased
1,119
Reduced
1,773
Closed
730

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$862M
2
BIDU icon
Baidu
BIDU
+$752M
3
TME icon
Tencent Music
TME
+$426M
4
KO icon
Coca-Cola
KO
+$424M
5
NVDA icon
NVIDIA
NVDA
+$383M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$981M
2
WFC icon
Wells Fargo
WFC
+$673M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$574M
4
MRNA icon
Moderna
MRNA
+$442M
5
DD icon
DuPont de Nemours
DD
+$415M

Sector Composition

Rank Sector Weight
1 Technology 16.45%
2 Consumer Discretionary 10.49%
3 Communication Services 9.04%
4 Healthcare 8.89%
5 Financials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FELE icon
3426
Franklin Electric
FELE
$4.56B
$440K ﹤0.01%
5,577
-10,523
-65% -$789K
MNDT
3427
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$440K ﹤0.01%
22,500
-30,000
-57% -$627K
PBCT
3428
DELISTED
People's United Financial Inc
PBCT
$440K ﹤0.01%
24,604
-459,513
-95% -$7.39M
LFCR icon
3429
Lifecore Biomedical
LFCR
$172M
$438K ﹤0.01%
41,321
-2,962
-7% -$33.3K
FNHC
3430
DELISTED
FedNat Holding Company Common Stock
FNHC
$437K ﹤0.01%
94,552
+39,425
+72% +$233K
NSCO.WS
3431
DELISTED
Nesco Holdings, Inc. Warrants, exerciseable for Common Stock
NSCO.WS
$435K ﹤0.01%
216,666
OPRX icon
3432
OptimizeRx
OPRX
$144M
$431K ﹤0.01%
8,838
-10,385
-54% -$501K
SIOX
3433
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$431K ﹤0.01%
+165,235
New +$467K
SI
3434
DELISTED
Silvergate Capital Corporation
SI
$430K ﹤0.01%
3,027
-16,879
-85% -$2M
RXT icon
3435
Rackspace Technology
RXT
$795M
$429K ﹤0.01%
+18,038
New +$389K
EQX icon
3436
Equinox Gold
EQX
$16.1B
$428K ﹤0.01%
53,605
-206,786
-79% -$1.91M
ATRI
3437
DELISTED
Atrion Corp
ATRI
$428K ﹤0.01%
668
-26
-4% -$17.2K
HHLA.U
3438
DELISTED
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
$428K ﹤0.01%
+42,400
New +$439K
MCD icon
3439
CALL
McDonald's
MCD
$193B
$426K ﹤0.01%
1,900
-130,300
-99% -$27.9M
ACET icon
3440
Adicet Bio
ACET
$83.3M
$425K ﹤0.01%
2,030
+498
+33% +$114K
NC icon
3441
NACCO Industries
NC
$309M
$425K ﹤0.01%
17,035
-534
-3% -$13.1K
CMCO icon
3442
Columbus McKinnon
CMCO
$518M
$424K ﹤0.01%
8,032
-481
-6% -$22.9K
AGCB
3443
DELISTED
Altimeter Growth Corp 2
AGCB
$424K ﹤0.01%
+40,822
New +$487K
GHM icon
3444
Graham Corp
GHM
$1.14B
$423K ﹤0.01%
29,692
+1,520
+5% +$23.7K
IBP icon
3445
Installed Building Products
IBP
$6.51B
$422K ﹤0.01%
+3,807
New +$432K
UBS icon
3446
UBS Group
UBS
$164B
$422K ﹤0.01%
27,197
+8,987
+49% +$138K
WTTR icon
3447
Select Water Solutions
WTTR
$2.48B
$422K ﹤0.01%
84,827
+46,293
+120% +$269K
BRY
3448
DELISTED
Berry Corp
BRY
$421K ﹤0.01%
+76,455
New +$376K
REX icon
3449
REX American Resources
REX
$1.4B
$420K ﹤0.01%
29,964
+4,668
+18% +$71.7K
PRA
3450
DELISTED
ProAssurance
PRA
$416K ﹤0.01%
15,541
-100,347
-87% -$2.32M

Similar funds

David Shaw's Q1 2021 Portfolio in Review

As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, David Shaw opened a new position in Baidu worth $627M.

  • David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
  • David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
  • David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
  • David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
  • David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
  • David Shaw opened 825 new positions and closed 730 in Q1 2021.
  • David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.

Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.